Carboxypeptidase A3 (CPA3): A novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells

Cancer Research

Volumn 59, Issue 12, 1999, Pages 2981-2988

  Huang, Haojie ^a   Reed, Christopher P ^a   Zhang, Jin San ^a   Shridhar, Viji ^a   Wang, Liang ^a   Smith, David I ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CARBOXYPEPTIDASE A; CARBOXYPEPTIDASE A3; ENZYME INHIBITOR; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE ISOLATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; SEQUENCE HOMOLOGY;

ACETYLATION; AMINO ACID SEQUENCE; BASE SEQUENCE; BUTYRIC ACIDS; CARBOXYPEPTIDASES; CARBOXYPEPTIDASES A; CELL DIFFERENTIATION; CLONING, MOLECULAR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INDUCTION; ENZYME INHIBITORS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HISTONES; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PROSTATIC NEOPLASMS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TISSUE DISTRIBUTION; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0033564458     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Kyprianou, N., English, H. F., and Isaacs, J. T. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res., 50: 3748-3753, 1990.
2. Crawford, E. D., Eisenberger, M. A., McLeod, D. G., Spaulding, J. T., Benson, R., Dorr, F. A., Blumentein, B. A., Davis, M. A., and Goodman, P. J. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N. Engl. J. Med., 321: 419-424, 1989.
3. Catalona, W. J. Management of cancer of the prostate. N. Engl. J. Med., 331: 996-1004, 1994.
4. McDonnell, T. J., Navone, N. M., Troncoso, P., Pisters, L. L., Conti, C., von Eschenbach, A. C., Brisbay, S., and Logothetis, C. J. Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer. J. Urol., 157: 569-574, 1997.
5. Thibault, A., Cooper, M. R., Figg, W. D., Venzon, D. J., Sartor, A. O., Tompkins, A. C., Weinberger, M. S., Headlee, D. J., McCall, N. A., Samid, D., and Myers, C. E. A phase 1 and pharmacokinetic study of intravenous phenylacetate in patients with cancer. Cancer Res., 54: 1690-1694, 1994.
6. Denmeade, S. R., Lin, X. S., and Isaacs J. T. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate, 28: 251-265, 1996.
7. Tang, D. G., and Porter, A. T. Target to apoptosis: a hopeful weapon for prostate cancer. Prostate, 32: 284-223, 1997.
8. Rivero, J. A., and Adunyah, S. E. Sodium butyrate stimulates PKC activation and induces differential expression of certain PKC isoforms during erythroid differentiation. Biochem. Biophys. Res. Commun., 248: 664-668, 1998.
9. Carducci, M. A., Nelson, J. B., Chan-Tack, K. M., Ayyagari, S. R., Sweatt, W. H., Campbell, P. A., Nelson, W. G., and Simons, J. W. Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate. Clin. Cancer Res., 2: 379-387, 1996.
10. Mandal, M., and Kumar, R. Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells. Cell Growth Differ., 7: 311-318, 1996.
11. Zhang, J. S., Nelson, M., Wang, L., Liu, W., Qian, C. P., Shridhar, V., Urrutia, R., and Smith, D. I. Identification and chromosomal localization of CTNNAL1, a novel protein homologous to α-catenin. Genomics, 54: 149-154, 1998.
12. Niitsu, N., Yamamoto-Yamaguchi, Y., Miyoshi, H., Shimizu, K., Ohki, M., Umeda, M., and Honma, Y. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells. Cell Growth Differ., 8: 319-326, 1997.
13. McIntyre, A., Young, G. P., Taranto, T., Gibson, P. R., and Ward, P. B. Different fibers have different regional effects on luminal contents of rat colon. Gastroenterology, 101: 1274-1281, 1991.
14. McIntyre, A., Gibson, P. R., and Young, G. P. Butyrate production from dietary fiber and protection against large bowel cancer in a rat model. Gut, 34: 386-391, 1993.
15. Candido, E. P., Reeves, R., and Davie, J. R. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell, 14: 105-113, 1978.
16. de Haan, J. B., Gevers, W., and Parker, M. I. Effects of sodium butyrate on the synthesis and methylation of DNA in normal cells and their transformed counterparts. Cancer Res., 46: 713-716, 1986.
17. Grunstein, M. Histone acetylation in chromatin structure and transcription. Nature (Lond.), 389: 349-352, 1997.
18. Lee, D. Y., Hayes, J. J., Pruss, D., and Wolffe, A. P. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell, 72: 73-84, 1993.
19. Wolffe, A. P. Histone deacetylase: a regulator of transcription. Science (Washington DC), 272: 371-372, 1996.
20. Trock, B., Lanza, E., and Greenwald, P. Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. J. Natl. Cancer Inst., 82: 650-661, 1990.
21. Archer, S. Y., Meng, S., Shei, A., and Hodin, R. A. p21WAF1/CIP1 is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc. Natl. Acad. Sci. USA, 95: 6791-6796, 1998.
22. Yang, X. J., Ogryzko, V. V., Nishikawa, J., Howard, B. H., and Nakatani, Y. A. p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature (Lond.), 382: 319-324, 1996.
23. Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., and Nakatani, Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell, 87: 953-959, 1996.
24. Bannister, A. J., and Kouzarides, T. The CBP co-activator is a histone acetyltransferase. Nature (Lond.), 384: 641-643, 1996.
25. Warrell, R. P. Jr., He, L. Z., Richon, V., Calleja, E., and Pandolfi, P. P. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J. Natl. Cancer Inst., 90: 1621-1625, 1998.
26. Samid, D., Hudgins, W. R., Shack, S., Liu, L., Prasanna, P., and Myers, C. E. Phenylacetate and phenylbutyrate as novel, nontoxic differentiation inducers. Adv. Exp. Med. Biol., 400A: 501-505, 1997.
27. Borner, M. M., Myers, C. E., Sartor, O., Sei, Y., Toko, T., Trepel, J. B, and Schneider, E. Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res., 55: 2122-2128, 1995.
28. Liang, P., and Pardee, A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (Washington DC), 257: 967-971, 1992.
29. Liang, P., Averboukh, L., and Pardee, A. B. Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res., 21: 3269-3275, 1993.
30. Catasus, L., Vendrell, J., Aviles, F. X., Carreira, S., Puigserver, A., and Billeter, M. The sequence and conformation of human pancreatic procarboxypeptidase A2. cDNA cloning, sequence analysis, and three-dimensional model. J. Biol. Chem., 270: 6651-6657, 1995.
31. Yoshida, M., Nomura, S., and Beppu, T. Effects of trichostatins on differentiation of murine erythroleukemia cells. Cancer Res., 47: 3688-3691, 1987.
32. Ogryzko, V. V., Hirai, T. H., Russanova, V. R., Barbie, D. A., and Howard, B. H. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol. Cell. Biol., 16: 5210-5218, 1996.
33. Aviles, F. X., Vendrell, J., Guasch, A., Coll, M., and Huber, R. Advances in metallo-procarboxypeptidases: emerging details on the inhibition mechanism and on the activation process. Eur. J. Biochem., 211: 381-389, 1993.
34. Song, L., and Fricker, L. D. Cloning and expression of human carboxypeptidase Z, a novel metallocarboxypeptidase. J. Biol. Chem., 272: 10543-10550, 1997.
35. von Heijne, G. Signal sequences: the limits of variation. J. Mol. Biol., 184: 99-105, 1985.
36. He, G. P., Mulse, A., Li, A. W., and Ro, H. S. A eukaryotic transcriptional repressor with carboxypeptidase activity. Nature (Lond.), 378: 92-96, 1995.
37. Layne, M. D., Endege, W. O., Jain, M. K., Yet, S. F., Hsieh, C. M., Chin, M. T., Perrella, M. A., Blanar, M. A., Haber, E., and Lee, M. E. Aortic carboxypeptidase-like protein, a novel protein with discoidin and carboxypeptidase-like domains, is upregulated during vascular smooth muscle cell differentiation. J. Biol. Chem., 273: 15654-15660, 1998.
38. Rehli, M., Krause, S. W., Kreutz, M., and Andreesen, R. Carboxypeptidase M is identical to the MAX. I antigen and its expression is associated with monocyte to macrophage differentiation. J. Biol. Chem., 270: 15644-15649, 1995.
39. Boffa, L. C., Lupton, J. R., Mariani, M. R., Ceppi, M., Newmark, H. L., Scalmati, A., and Lipkin, M. Modulation of colonic epithelial cell proliferation, histone acetylation, and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res., 52: 5906-5912, 1992.
40. Qiu, Y., Robinson, D., Pretlow, T. G., and Kung, H. J. Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc. Natl. Acad. Sci. USA, 95: 3644-3649, 1998.
41. Kremer, R., Goltzman, D., Amizuka, N., Webber, M. M., and Rhim, J. S. ras activation of human prostate epithelial cells induces overexpression of parathyroid hormone-related peptide. Clin. Cancer Res., 3: 855-859, 1997.
42. Carter, R. E., Feldman, A. R., and Coyle, J. T. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc. Natl. Acad. Sci. USA, 93: 749-753, 1996.
43. Israeli, R. S., Powell, C. T., Fair, W. R., and Heston, W. D. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res., 53: 227-230, 1993.